Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 2
Suggested positive control: 3-OHKYN modified BSA.
3-Hydroxykynurenine (3-HK) is a metabolite in the kynurenine pathway of tryptophan catabolism, primarily involved in various physiological and pathological processes. It is a branch of the kynurenine monooxygenase (KMO) pathway and has been recognized for its dual role in the central nervous system. Structurally, 3-HK is an intermediate metabolite that undergoes autoxidation, which results in a range of products that may contribute to protein modification and cytotoxicity, especially in the context of oxidative stress. Although 3-HK has antioxidant and free radical scavenging properties, it is largely characterized as a toxic metabolite that can induce oxidative damage and cell death. The neuronal damage associated with 3-HK is mediated by free radicals rather than glutamate receptors. Altered levels of 3-HK have been observed in patients with various disorders, suggesting its potential involvement in neurodegenerative diseases. Research continues to explore the balance between its damaging and protective roles, with implications for therapeutic interventions targeting oxidative stress and neuroprotection.
仅用于科研。不用于诊断过程。未经明确授权不得转售。